Spravato (Esketamine) in Tampa, St. Petersburg, and Brandon
Spravato is an FDA-approved treatment for major depressive disorder (specifically for depression that has not responded well to antidepressants) since 2019. Offered at our Tampa, St. Petersburg, and Brandon locations, Spravato is:
- Administered via nasal spray
- Covered by all commercial insurances and Medicare.
- Requires in-office treatments:
- Twice weekly for four weeks, then
- Once weekly for four weeks, then
- Continued weekly treatments or every other week treatments for maintenance
- Individual treatment duration: 2 hours (nasal spray administered, then 2 hour monitoring period)
- Restrictions: Cannot drive for rest of day after treatment